•  
  •  
 

Author ORCID Identifier

https://orcid.org/0009-0009-2704-0698

Corresponding Author

Isha Kumthekar

ishakumthekar123@gmail.com

Abstract

Background: The relationship between COVID-19 vaccination and the incidence of myocardial infarction remains a topic of debate. The study aimed to analyze the demographic, clinical, and outcome characteristics of MI patients post-vaccination in India, focusing on differences between Covishield and Covaxin recipients.

Methods: The retrospective observational study included 303 MI patients admitted to a tertiary care center. Data were collected on demographics, comorbidities, vaccination status, ICU admissions, and outcomes. The Charlson Comorbidity Index (CCI) was used to assess disease severity. Statistical analyses evaluated the associations between vaccination status, clinical parameters, and mortality.

Results: Among the study population, 74.3% were males, and 32.7% were aged 51–60 years, reflecting the typical Indian MI demographic. Covishield was the predominant vaccine received (80.9%), followed by Covaxin (15.2%), and 4.0% were unvaccinated. No significant differences were observed in CCI scores across vaccination groups. However, the mean CCI was significantly

higher in deceased patients than in survivors. ICU admission rates were higher in Covishield recipients (53.1%) than in Covaxin recipients (41.3%), but this difference was not statistically significant. Mortality rates were slightly higher in the Covishield group (11.1%) compared to the Covaxin group (8.9%), although this difference wasn't significant. ICU management was associated with better survival rates compared to ward care.

Conclusion: The study contributes to the growing body of evidence supporting the cardiovascular safety of COVID-19 vaccines. While vaccination wasn't significantly associated with increased MI risk or mortality, higher comorbidity burdens were linked to worse outcomes.

Publication Date

2025

Publisher

JSS Academy of Higher Education & Research

Keywords

SARS-CoV-2, COVID-19, Covishield, Covaxin, Acute myocardial infarction

Word Count

3982

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.